Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Protein-Losing Enteropathies

1-anilino-8-naphthalenesulfonate has been researched along with Protein-Losing Enteropathies in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leyland, FC1
Fosbrooke, AS1
Lloyd, JK1
Segall, MM1
Tamir, I1
Tomkins, R1
Wolff, OH1

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Protein-Losing Enteropathies

ArticleYear
Use of medium-chain triglyceride diets in children with malabsorption.
    Archives of disease in childhood, 1969, Volume: 44, Issue:234

    Topics: Bile; Celiac Disease; Child; Child, Preschool; Cholestasis; Cholestyramine Resin; Diet Therapy; Diet

1969